IP Library Granted Patent US 12,239,658
Granted Patent B2
US 12,239,658 · App. 17/691,263 · Granted Mar 4, 2025

Preservative-free contact lens treating solution comprising hyaluronic acid and erythritol

Inventors: Vicki Barniak (Fairport, NY); Catherine Scheuer (West Henrietta, NY); William T. Reindel (Webster, NY); John Michael Duex (Livonia, NY); Andrea E. Siverling (Rochester, NY)
Assignee: BAUSCH + LOMB IRELAND LIMITED
A61K31/728A01N33/12A01N37/52A01P1/00A61K9/0048A61K47/02A61K47/10A61K47/26A61L12/142A61L12/145A61P27/04C11D1/66C11D1/722C11D3/0078C11D3/046C11D3/2065C11D3/222C11D3/227C11D3/48
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,239,658
App. No.
17/691,263
Granted
Mar 4, 2025
Kind
B2
Abstract

A preservative-free contact lens treating solution includes (a) about 0.005 to about 2 wt. %, based on the total weight of the preservative-free contact lens treating solution, of hyaluronic acid or a salt thereof; (b) about 0.01 to about 1 wt. %, based on the total weight of the preservative-free contact lens treating solution, of erythritol; (c) one or more nonionic surfactants; (d) sodium chloride, potassium chloride or any combination thereof; and (e) one or more buffers.

Claims (42)

1. A preservative-free contact lens treating solution, comprising consisting of:

(a) about 0.005 to about 2 wt. %, based on the total weight of the preservative-free contact lens treating solution, of hyaluronic acid or a salt thereof;

(b) about 0.01 to about 1 wt. %, based on the total weight of the preservative-free contact lens treating solution, of erythritol;

(c) one or more nonionic surfactants;

(d) one or more of sodium chloride and potassium chloride;

(e) one or more buffers selected from the group consisting of boric acid, a salt of boric acid and combinations thereof;

(f) one or more lubricants; and

(g) water.

2. The preservative-free contact lens treating solution of claim 1 , consisting of:

(a) about 0.01 to about 0.2 wt. %, based on the total weight of the preservative-free contact lens treating solution, of hyaluronic acid or a salt thereof; and

(b) about 0.05 to about 0.5 wt. %, based on the total weight of the preservative-free contact lens treating solution, of erythritol.

3. The preservative-free contact lens treating solution of claim 1 , wherein the one or more nonionic surfactants comprise one or more of a poloxamer and a poloxamine.

4. The preservative-free contact lens treating solution of claim 1 , consisting of:

about 0.05 to about 5 wt. %, based on the total weight of the preservative-free contact lens treating solution, of the one or more nonionic surfactants;

about 0.01 to about 5 wt. %, based on the total weight of the preservative-free contact lens treating solution, of the one or more of sodium chloride and potassium chloride; and

about 0.1 to about 10% (w/w) of the one or more buffers.

5. The preservative-free contact lens treating solution of claim 1 , wherein the one or more lubricants are glycerol.

6. The preservative-free contact lens treating solution of claim 1 , consisting of about 0.01 to about 5 wt. %, based on the total weight of the preservative-free contact lens treating solution, of the one or more lubricants.

7. The preservative-free contact lens treating solution of claim 1 , in the form of eye drops.

8. A method of rewetting a contact lens, the method consisting of:

administering a preservative-free contact lens treating solution to a contact lens while worn on the eye, wherein the preservative-free contact lens treating solution consists of (a) about 0.005 to about 2 wt. %, based on the total weight of the preservative-free contact lens treating solution, of hyaluronic acid or a salt thereof; (b) about 0.01 to about 1 wt. %, based on the total weight of the preservative-free contact lens treating solution, of erythritol; (c) one or more nonionic surfactants; (d) one or more of sodium chloride and potassium chloride; (e) one or more buffers; (f) one or more lubricants; and (g) water.

9. The method of claim 8 , wherein the preservative-free contact lens treating solution consists of:

about 0.05 to about 5 wt. %, based on the total weight of the preservative-free contact lens treating solution, of the one or more nonionic surfactants;

about 0.01 to about 5 wt. %, based on the total weight of the preservative-free contact lens treating solution, of the one or more of sodium chloride and potassium chloride; and

about 0.1 to about 10% (w/w) of the one or more buffers.

10. The method of claim 8 , wherein the one or more lubricants are glycerol.

11. The method of claim 9 , wherein the preservative-free contact lens treating solution consists of about 0.01 to about 5 wt. %, based on the total weight of the preservative-free contact lens treating solution, of the one or more lubricants.

12. The method of claim 8 , wherein the preservative-free contact lens treating solution is in the form of eye drops.

13. A system useful as an artificial tear or for rewetting or lubricating contact lenses while in the eye, the system including at least a drop dispenser capable of holding between about 1 and about 30 ml of a preservative-free contact lens treating solution that consists of (a) about 0.005 to about 2 wt. %, based on the total weight of the preservative-free contact lens treating solution, of hyaluronic acid or a salt thereof; (b) about 0.01 to about 1 wt. %, based on the total weight of the preservative-free contact lens treating solution, of erythritol; (c) one or more nonionic surfactants; (d) one or more of sodium chloride and potassium chloride; (e) one or more buffers; (f) one or more lubricants; and (g) water.

14. The system of claim 13 , wherein the preservative-free contact lens treating solution consists of:

about 0.05 to about 5 wt. %, based on the total weight of the preservative-free contact lens treating solution, of the one or more nonionic surfactants;

about 0.01 to about 5 wt. %, based on the total weight of the preservative-free contact lens treating solution, of the one or more of sodium chloride and potassium chloride; and

about 0.1 to about 10% (w/w) of the one or more buffers.

15. The system of claim 13 , wherein the one or more nonionic surfactants comprise one or more of a poloxamer and a poloxamine.

16. The system of claim 13 , wherein the preservative-free contact lens treating solution consists of:

about 0.05 to about 5 wt. %, based on the total weight of the preservative-free contact lens treating solution, of the one or more nonionic surfactants;

about 0.01 to about 5 wt. %, based on the total weight of the preservative-free contact lens treating solution, of the one or more of sodium chloride and potassium chloride;

about 0.1 to about 10% (w/w) of the one or more buffers; and

about 0.01 to about 5 wt. %, based on the total weight of the preservative-free contact lens treating solution, of the one or more lubricants.

17. The system of claim 13 , wherein the preservative-free contact lens treating solution consists of about 0.01 to about 5 wt. %, based on the total weight of the preservative- free contact lens treating solution, of the one or more lubricants.

18. The system of claim 13 , wherein the preservative-free contact lens treating solution is in the form of eye drops.

19. The system of claim 13 , wherein the one or more lubricants are glycerol.

Assignments (9)
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (062134/0854) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072976/0492 →
PATENT SECURITY AGREEMENT Recorded Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
SECURITY INTEREST Recorded Feb 12, 2024
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 066552/0041 →
PARTIAL RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS Recorded Mar 3, 2023
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 062945/0299 →
PARTIAL RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS Recorded Mar 3, 2023
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 062945/0360 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 15, 2022
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A. AS COLLATERAL AGENT
Reel/Frame 062134/0854 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2022
From: BARNIAK, VICKI; SCHEUER, CATHERINE; REINDEL, WILLIAM T.; DUEX, JOHN MICHAEL; GIALLOMBARDO, ANDREA E.
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 061408/0229 →
SECURITY INTEREST Recorded Mar 30, 2022
From: BAUSCH+LOMB IRELAND LIMITED; BAUSCH HEALTH IRELAND LIMITED; BAUSCH & LOMB INCORPORATED; SALIX PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 059446/0670 →
SECURITY INTEREST Recorded Mar 30, 2022
From: BAUSCH+LOMB IRELAND LIMITED; BAUSCH HEALTH IRELAND LIMITED; BAUSCH & LOMB INCORPORATED; SALIX PHARMACEUTICALS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 059446/0722 →